ArticleScience translational medicine2023

Proteomics of brain, CSF, and plasma identifies molecular signatures for distinguishing sporadic and genetic Alzheimer's disease.

Yun Ju Sung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.